Hepatocyte transplantation for inherited metabolic diseases of the liver
C Jorns, E C Ellis, G Nowak, B Fischler, A Nemeth, S C Strom, B G Ericzon, C Jorns, E C Ellis, G Nowak, B Fischler, A Nemeth, S C Strom, B G Ericzon
Abstract
Inherited metabolic diseases of the liver are characterized by deficiency of a hepatic enzyme or protein often resulting in life-threatening disease. The remaining liver function is usually normal. For most patients, treatment consists of supportive therapy, and the only curative option is liver transplantation. Hepatocyte transplantation is a promising therapy for patients with inherited metabolic liver diseases, which offers a less invasive and fully reversible approach. Procedure-related complications are rare. Here, we review the experience of hepatocyte transplantation for metabolic liver diseases and discuss the major obstacles that need to be overcome to establish hepatocyte transplantation as a reliable treatment option in the clinic.
Trial registration: ClinicalTrials.gov NCT01345578.
© 2012 The Association for the Publication of the Journal of Internal Medicine.
Source: PubMed